METCALF; Andrew T.

Patent Applications and Registrations

Patent applications and USPTO patent grants for METCALF; Andrew T..The latest application filed is for "fused heterocyclic compounds as ret kinase inhibitors".

Company Profile

21.18.24

METCALF; Andrew T. - Indianapolis IN
Metcalf; Andrew T. - Boulder CO

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Fused Heterocyclic Compounds As Ret Kinase Inhibitors App 20220112214 - BLAKE; James F. ; et al.	2022-04-14
Bicyclic fused pyridine compounds as inhibitors of TAM kinases Grant 11,247,990 - Allen , et al. February 15, 2	2022-02-15
Process For The Preparation Of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6- -diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-car- Bonitrile App 20210380609 - EARY; Charles Todd ; et al.	2021-12-09
Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6- -diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-car- bontrile Grant 11,098,064 - Eary , et al. August 24, 2	2021-08-24
Substituted Pyrazolo[1,5-a]pyridine Compounds As Ret Kinase Inhibitors App 20210186959 - Andrews; Steven W. ; et al.	2021-06-24
Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors Grant 10,953,005 - Andrews , et al. March 23, 2	2021-03-23
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors Grant 10,881,652 - Andrews , et al. January 5, 2	2021-01-05
SUBSTITUTED PYRAZOLO[3,4-d]PYRIMIDINE COMPOUNDS AS RET KINASE INHIBITORS App 20200399279 - BLAKE; James F. ; et al.	2020-12-24
Substituted Pyrazolo[1,5-a]pyridine Compounds As Ret Kinase Inhibitors App 20200383966 - ANDREWS; Steven W. ; et al.	2020-12-10
Substituted Pyrrolo[2,3-d]pyrimidines Compounds As Ret Kinase Inhibitors App 20200339589 - BLAKE; James F. ; et al.	2020-10-29
Substituted Pyrazolyl[4,3-c]pyridine Compounds As Ret Kinase Inhibitors App 20200339579 - WALLS; Shane M. ; et al.	2020-10-29
Process For The Preparation Of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6- -diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-car- Bonitrile App 20200308194 - EARY; Charles Todd ; et al.	2020-10-01
2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases Grant 10,766,881 - Andrews , et al. Sep	2020-09-08
Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6- -diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-car- bonitrile Grant 10,745,419 - Eary , et al. A	2020-08-18
Crystalline forms Grant 10,584,124 - Metcalf , et al.	2020-03-10
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors Grant 10,555,944 - Andrews , et al. Feb	2020-02-11
Substituted Pyrazolo[1,5-a]pyridine Compounds As Ret Kinase Inhibitors App 20200030311 - ANDREWS; Steven W. ; et al.	2020-01-30
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors Grant 10,441,581 - Andrews , et al. Oc	2019-10-15
2-aryl- And 2-heteroaryl-substituted 2-pyridazin-3(2h)-one Compounds As Inhibitors Of Fgfr Tyrosine Kinases App 20190300511 - Andrews; Steven W. ; et al.	2019-10-03
Crystalline Forms App 20190263811 - Metcalf; Andrew T. ; et al.	2019-08-29
Substituted Pyrazolo[1,5-a]pyridine Compounds As Ret Kinase Inhibitors App 20190183886 - Andrews; Steven W. ; et al.	2019-06-20
Process For The Preparation Of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6- -diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-car- Bonitrile App 20190106438 - Eary; Charles Todd ; et al.	2019-04-11
2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases Grant 10,208,024 - Andrews , et al. Feb	2019-02-19
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors Grant 10,172,845 - Andrews , et al. J	2019-01-08
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors Grant 10,172,851 - Andrews , et al. J	2019-01-08
Serine/threonine kinase inhibitors Grant 10,154,995 - Blake , et al. Dec	2018-12-18
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors Grant 10,144,734 - Andrews , et al. De	2018-12-04
Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors Grant 10,137,124 - Andrews , et al. November 27, 2	2018-11-27
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors Grant 10,112,942 - Andrews , et al. October 30, 2	2018-10-30
Substituted Pyrazolo[1,5-a]pyridine Compounds As Ret Kinase Inhibitors App 20180148445 - Andrews; Steven W. ; et al.	2018-05-31
Substituted Pyrazolo[1,5-a]pyridine Compounds As Ret Kinase Inhibitors App 20180133200 - Andrews; Steven W. ; et al.	2018-05-17
Substituted Pyrazolo[1,5-a]pyridine Compounds As Ret Kinase Inhibitors App 20180133213 - Andrews; Steven W. ; et al.	2018-05-17
Substituted Pyrazolo[1,5-a]pyridine Compounds As Ret Kinase Inhibitors App 20180133207 - Andrews; Steven W. ; et al.	2018-05-17
Substituted Pyrazolo[1,5-a]pyridine Compounds As Ret Kinase Inhibitors App 20180134702 - Andrews; Steven W. ; et al.	2018-05-17
Substituted Pyrazolo[1,5-a]pyridine Compounds As Ret Kinase Inhibitors App 20180134703 - Andrews; Steven W. ; et al.	2018-05-17
Serine/threonine Kinase Inhibitors App 20170348310 - Blake; James F. ; et al.	2017-12-07
Serine/threonine kinase inhibitors Grant 9,763,942 - Blake , et al. September 19, 2	2017-09-19
2-aryl- And 2-heteroaryl-substituted 2-pyridazin-3(2h)-one Compounds As Inhibitors Of Fgfr Tyrosine Kinases App 20170260168 - Andrews; Steven W. ; et al.	2017-09-14
Serine/threonine kinase inhibitors Grant 9,670,208 - Blake , et al. June 6, 2	2017-06-06
Serine/threonine Kinase Inhibitors App 20160303126 - Blake; James F. ; et al.	2016-10-20
Serine/threonine Kinase Inhibitors App 20160304519 - Blake; James F. ; et al.	2016-10-20
Compounds For Treating Neurodegenerative Diseases App 20120157448 - Cook; Adam ; et al.	2012-06-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.